Ophthalmic gallium compositions and methods of their use
OwnerLawrence R. Bernsteininventor
Life of this patent
Estimating the term…
Abstract
Provided are ophthalmic pharmaceutical compositions comprising gallium. These compositions are designed primarily for topical ocular and intraocular administration. Also provided are methods of use for the compositions in the treatment of human and veterinary diseases and disorders. Treatable diseases and disorders include adverse conditions of the eye and adnexal tissues of the eye. These adverse conditions comprise inflammatory conditions, infections, cancers, and other pathological conditions.
Claims50
An ophthalmic pharmaceutical composition comprising a pharmaceutically acceptable gallium compound and a carrier suitable for ophthalmic administration.
A method for treating an adverse condition of the eye or adnexal eye tissue in an individual afflicted with such a condition, comprising administering to the affected eye or eyes a therapeutically effective amount of a ophthalmically administrable pharmaceutical composition comprising a carrier suitable for ophthalmic administration and an active agent, wherein the active agent is a pharmaceutically acceptable gallium compound.
Dependencies are inferred from the claim text.